DK2788014T3 - Anvendelse af væksthormonfragmenter - Google Patents
Anvendelse af væksthormonfragmenter Download PDFInfo
- Publication number
- DK2788014T3 DK2788014T3 DK12855593.5T DK12855593T DK2788014T3 DK 2788014 T3 DK2788014 T3 DK 2788014T3 DK 12855593 T DK12855593 T DK 12855593T DK 2788014 T3 DK2788014 T3 DK 2788014T3
- Authority
- DK
- Denmark
- Prior art keywords
- fragments
- growth hormon
- hormon
- growth
- hormon fragments
- Prior art date
Links
- 239000012634 fragment Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Biotechnology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2011905133A AU2011905133A0 (en) | 2011-12-09 | Use of growth hormone fragments | |
| AU2011905132A AU2011905132A0 (en) | 2011-12-09 | Use of growth hormone fragments | |
| AU2012901398A AU2012901398A0 (en) | 2012-04-10 | Use of growth hormone fragments | |
| AU2012901400A AU2012901400A0 (en) | 2012-04-10 | Use of growth hormone fragments | |
| PCT/AU2012/001497 WO2013082667A1 (en) | 2011-12-09 | 2012-12-07 | Use of growth hormone fragments |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2788014T3 true DK2788014T3 (da) | 2020-01-02 |
Family
ID=48573423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12855593.5T DK2788014T3 (da) | 2011-12-09 | 2012-12-07 | Anvendelse af væksthormonfragmenter |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10111933B2 (da) |
| EP (1) | EP2788014B8 (da) |
| JP (2) | JP6363952B2 (da) |
| KR (2) | KR102148910B1 (da) |
| CN (2) | CN103987402B (da) |
| AU (1) | AU2012327167B2 (da) |
| BR (1) | BR112014013757A2 (da) |
| CA (1) | CA2857686C (da) |
| DK (1) | DK2788014T3 (da) |
| ES (1) | ES2764106T3 (da) |
| RU (1) | RU2639474C2 (da) |
| WO (1) | WO2013082667A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012327167B2 (en) * | 2011-12-09 | 2015-04-23 | Metabolic Pharmaceuticals Pty Ltd | Use of growth hormone fragments |
| RU2020123165A (ru) * | 2018-01-15 | 2022-02-17 | Лэйтерал Ип Пти Лтд | Пептиды и их применение |
| KR20220027884A (ko) * | 2019-05-31 | 2022-03-08 | 레터럴 아이피 피티와이 리미티드 | 펩티드 및 그의 용도 |
| KR102507333B1 (ko) | 2019-12-12 | 2023-03-07 | 조선대학교산학협력단 | 악테오사이드를 포함하는 약학적 조성물 및 건강기능식품 |
| CN115243702A (zh) * | 2019-12-27 | 2022-10-25 | 横向知识产权私人有限公司 | 环肽受体羊毛硫氨酸合成酶c样蛋白(lancl)及其用途 |
| AU2021237981A1 (en) * | 2020-03-16 | 2022-10-13 | Lateral IP Pty Ltd | Compositions for treating respiratory tract infection and uses thereof |
| AU2022269043A1 (en) * | 2021-05-07 | 2023-11-30 | Lateral Pharma Pty Ltd | Compositions for treating inflammatory airway disease and uses thereof |
| CN114380902B (zh) * | 2021-12-29 | 2023-06-16 | 江苏诺泰澳赛诺生物制药股份有限公司 | 一种hgh(176-191)的制备方法 |
| CN116333091A (zh) * | 2023-03-31 | 2023-06-27 | 江苏诺泰澳赛诺生物制药股份有限公司 | 连续流固相合成制备hgh(176-191)的方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU693478B2 (en) * | 1994-11-10 | 1998-07-02 | Metabolic Pharmaceuticals Limited | Treatment of obesity |
| WO1999012969A1 (en) * | 1997-09-08 | 1999-03-18 | Metabolic Pharmaceuticals Ltd. | Treatment of obesity |
| AUPQ387599A0 (en) * | 1999-11-05 | 1999-12-02 | Metabolic Pharmaceuticals Limited | Product and method for control of obesity |
| WO2002016551A2 (en) | 2000-08-18 | 2002-02-28 | University Of Massachusetts Medical Center | Trance regulation of chondrocyte differentiation |
| AUPQ981700A0 (en) * | 2000-09-01 | 2000-09-28 | Metabolic Pharmaceuticals Limited | Product and method for control of obesity |
| EP1501539A1 (en) * | 2002-05-03 | 2005-02-02 | Metabolic Pharmaceuticals Ltd. | Method for control of depression using c terminal growth hormone (gh) fragment |
| US20040142870A1 (en) * | 2002-11-20 | 2004-07-22 | Finn Rory F. | N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof |
| CN101080238A (zh) * | 2003-05-09 | 2007-11-28 | 尼奥斯技术有限公司 | 人生长激素糖基化突变体的制备方法和组合物 |
| BR0318426A (pt) * | 2003-07-29 | 2006-08-01 | Ares Trading Sa | uso de hormÈnio de crescimento humano em atrofia multissistêmica |
| EP1681306B1 (en) | 2003-10-29 | 2013-02-20 | Teijin Limited | Hyaluronic acid compound, hydrogel thereof and material for treating joint |
| EP2298862B1 (en) | 2004-03-22 | 2017-08-30 | Mesoblast International Sàrl | Mesenchymal stem cells and uses therefor |
| ES2391853T3 (es) * | 2004-05-04 | 2012-11-30 | Metabolic Pharmaceuticals Ltd. | Métodos para prevenir o tratar trastornos óseos |
| EP1781698B1 (en) | 2004-07-20 | 2016-07-06 | Genentech, Inc. | Compositions and methods of using angiopoietin-like 4 protein |
| US7998930B2 (en) * | 2004-11-04 | 2011-08-16 | Hanall Biopharma Co., Ltd. | Modified growth hormones |
| JP4388483B2 (ja) | 2004-12-27 | 2009-12-24 | 株式会社ツーセル | 間葉系幹細胞の骨化及び／又は軟骨化促進剤と骨化及び／又は軟骨化促進方法 |
| WO2006133477A1 (en) * | 2005-06-14 | 2006-12-21 | Metabolic Pharmaceuticals Limited | Peptides corresponding to human growth hormone |
| RU2008105545A (ru) * | 2005-08-30 | 2009-10-10 | Ново Нордиск Хелс Кеа Аг (Ch) | Жидкие препараты пэгилированного гормона роста |
| WO2007068039A1 (en) * | 2005-12-12 | 2007-06-21 | Metabolic Pharmaceuticals Limited | Treatment of weight gain in estrogen deficient mammals |
| ES2587400T3 (es) | 2008-04-29 | 2016-10-24 | Ascendis Pharma Growth Disorders Division A/S | Compuestos de hormona de crecimiento humana recombinante pegilada |
| WO2009156511A2 (en) * | 2008-06-27 | 2009-12-30 | Novo Nordisk A/S | N-glycosylated human growth hormone with prolonged circulatory half-life |
| EP2324056A1 (en) * | 2008-09-09 | 2011-05-25 | Novo Nordisk Health Care AG | Growth hormone conjugate with increased stability |
| US20100197590A1 (en) * | 2009-02-03 | 2010-08-05 | Pfizer Inc | 4-AMINO-7,8-DIHYDROPYRIDO[4,3-d]PYRIMIDIN-5(6H)-ONE DERIVATIVES |
| WO2011038205A2 (en) | 2009-09-25 | 2011-03-31 | Curna, Inc. | Treatment of growth hormone (gh) related diseases by inhibition of natural antisense transcript to gh |
| CN102190721A (zh) * | 2010-03-03 | 2011-09-21 | 北京双鹭药业股份有限公司 | 一种长效生长激素 |
| AU2012327167B2 (en) * | 2011-12-09 | 2015-04-23 | Metabolic Pharmaceuticals Pty Ltd | Use of growth hormone fragments |
-
2012
- 2012-12-07 AU AU2012327167A patent/AU2012327167B2/en active Active
- 2012-12-07 KR KR1020197033998A patent/KR102148910B1/ko active IP Right Grant
- 2012-12-07 DK DK12855593.5T patent/DK2788014T3/da active
- 2012-12-07 JP JP2014545042A patent/JP6363952B2/ja active Active
- 2012-12-07 CN CN201280060658.0A patent/CN103987402B/zh active Active
- 2012-12-07 BR BR112014013757A patent/BR112014013757A2/pt active Search and Examination
- 2012-12-07 WO PCT/AU2012/001497 patent/WO2013082667A1/en active Application Filing
- 2012-12-07 US US14/363,256 patent/US10111933B2/en active Active
- 2012-12-07 CN CN201910445102.7A patent/CN110448683A/zh active Pending
- 2012-12-07 KR KR1020147017931A patent/KR20140101397A/ko active Application Filing
- 2012-12-07 RU RU2014124030A patent/RU2639474C2/ru active
- 2012-12-07 EP EP12855593.5A patent/EP2788014B8/en active Active
- 2012-12-07 CA CA2857686A patent/CA2857686C/en active Active
- 2012-12-07 ES ES12855593T patent/ES2764106T3/es active Active
-
2018
- 2018-03-22 JP JP2018055232A patent/JP6786544B2/ja active Active
- 2018-09-19 US US16/136,167 patent/US10758593B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2788014B1 (en) | 2019-09-18 |
| CN103987402B (zh) | 2019-06-18 |
| WO2013082667A1 (en) | 2013-06-13 |
| JP2018118986A (ja) | 2018-08-02 |
| JP2015500813A (ja) | 2015-01-08 |
| US10758593B2 (en) | 2020-09-01 |
| AU2012327167A1 (en) | 2013-06-27 |
| AU2012327167B2 (en) | 2015-04-23 |
| CA2857686C (en) | 2023-01-17 |
| JP6363952B2 (ja) | 2018-07-25 |
| CN110448683A (zh) | 2019-11-15 |
| CA2857686A1 (en) | 2013-06-13 |
| CN103987402A (zh) | 2014-08-13 |
| EP2788014B8 (en) | 2019-10-23 |
| RU2639474C2 (ru) | 2017-12-21 |
| KR20190132552A (ko) | 2019-11-27 |
| ES2764106T3 (es) | 2020-06-02 |
| EP2788014A4 (en) | 2015-10-28 |
| RU2014124030A (ru) | 2016-01-27 |
| EP2788014A1 (en) | 2014-10-15 |
| US20190099472A1 (en) | 2019-04-04 |
| BR112014013757A2 (pt) | 2019-08-27 |
| US20150079044A1 (en) | 2015-03-19 |
| JP6786544B2 (ja) | 2020-11-18 |
| KR20140101397A (ko) | 2014-08-19 |
| KR102148910B1 (ko) | 2020-08-28 |
| US10111933B2 (en) | 2018-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2771364T3 (da) | Fremstilling af heterodimere proteiner | |
| DK2768524T3 (da) | PD-L1-baseret immunterapi | |
| DK3235812T3 (da) | Deutererede derivater af ivacaftor | |
| DK2717941T3 (da) | Behandling af cancer | |
| DK2785349T3 (da) | Kombinationsbehandling af cancer | |
| UY4115Q (es) | Reloj | |
| CO6960555A2 (es) | Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
| DK2788014T3 (da) | Anvendelse af væksthormonfragmenter | |
| BR112014005359A2 (pt) | prendedor de grampo - estalar de fechar | |
| BR112014002563A2 (pt) | sonda cirúrgica óptica | |
| DK2555704T3 (da) | Visning af hæmostatiske parametre | |
| DK2733803T4 (da) | Sektion af kabelbakke | |
| DK2800572T3 (da) | Sammensætning af ellagitannin-rige ekstrakter | |
| DK2692211T3 (da) | Lysdæmperstyring af vinkellysfordeling | |
| BR112014012043A2 (pt) | emplastro | |
| BR112013025721A8 (pt) | métodos de fabricação de elementos absorventes volumosos | |
| DK2731572T3 (da) | Forbedringer af indgivelsesanordninger | |
| FR2978964B1 (fr) | Composition vaccinale anti-il-6 | |
| DK2780003T3 (da) | Behandling af binyrebarkinsufficiens | |
| DK2731573T3 (da) | Forbedringer af indgivelsesanordninger | |
| BR112014012044A2 (pt) | emplasto | |
| DK3228631T3 (da) | Behandling af respiratoriske tilstande | |
| BR112013030519A2 (pt) | semente fabricada | |
| ES1075493Y (es) | Cebo artificial de pesca | |
| DK2588462T3 (da) | Metronidazolestere til behandling af rosacea |